Nontuberculous Mycobacterium Treatment Market Size & Share, by Drug Type (Clarithromycin, Azithromycin, Rifampin, Rifabutin, Ethambutol, Streptomycin, Amikacin); End-user (Hospitals, Private Clinics, Drug Stores, Retail Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

Nontuberculous Mycobacterium Treatment Market size was valued at USD 9.11 billion in 2023 and is likely to reach USD 12.72 billion by 2036, registering around 2.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of nontuberculous mycobacterium treatment is estimated at USD 9.3 billion. The growth of the market can be attributed to the increasing prevalence of nontuberculous mycobacterial lung disease, especially amongst the elderly population across the globe. Moreover, the rising geriatric population on a global level, is further estimated to boost the market growth. According to the data by the World Bank, 723,484,054 individuals were aged above 64 years of age, as of 2020. Furthermore, the high occurrence of various lung-related issues amongst people are further projected to boost the market growth. As per the data by the National Organization for Rare Disorder, chronic lung infection is the most common complication affecting approximately 94% of individuals. Additionally, increasing health awareness amongst people, government initiatives to provide efficient health facilities, and growing health expenditure are estimated to boost the market growth.